Results of ADVAVCE study - an advance in the treatment of hypertension and diabetes mellitus
https://doi.org/10.18705/1607-419X-2008-14-3-288-293
References
1. dler A., Stratton I.M., Neil H., et al. Association of systolic blood pressure with macrovascular and micro vascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412-419.
2.
3. The Task Force for the management of arterial hypertension of the European Society of Hypertension and of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105-1187.
4.
5. The Task Force on Diabetes and Cardiovascular Disease of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular disease: executive summary. Eur Heart J 2007; 28: 88-136.
6.
7. Stratton I.M., Adler A.L., Neil H.A. et al. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-412.
8.
9. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
10.
11. The ADVANCE Collaborative Group: Rationale and design of the ADVANCE Study: a randomised trial of blood pressure lowering and intensive glucose control in high risk individuals with Type 2 diabetes mellitus. J Hypertens 2001; 19: 21-28.
12.
13. ADVANCE Collaborative Group/ ADVANCE - Action in diabetes and vascular disease: patient recruitment and characteristics of the study population at baseline. Diabet./ Med./ 2005; 1-7.
14.
15. ADVANCE Collaborative Group. Effects of fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370: 828-840.
16.
17. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560-2572.
18.
19. Yeon SS, Nesto RW. Implications of intensive glycemic control on cardiovascular disease: early reports from the ACCORD and ADVANCE Trials. Rev Cardiovasc Med 2008;9(1):l-4.
20.
21. Cefalu WT, Watson K. Intensive glycemic control and cardiovascular disease. Observations from the ACCORD study. Diabetes 2008; 57: 1163-1165.
22.
23. Goede P, Lund-Andersen H, Parving HH, et al. Effect of multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-589.
24.
25. Holman RR, Paul SJ, Bethel MA, et al. Ten-year follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 2008; [ Epub ahead of print].
26.
27. Chalmers J. ADVANCE: new results. EASD 2008 Meeting, September 8. Oral presentation.
28.
Review
For citations:
Karpov Y. Results of ADVAVCE study - an advance in the treatment of hypertension and diabetes mellitus . "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2008;14(3):288-293. (In Russ.) https://doi.org/10.18705/1607-419X-2008-14-3-288-293